1= Normal >-1.0 2= Osteopenia <-1.0, >-2.5 3= Osteoporosis <-2.5 4= Severe osteoporosis <-2.5 plus fragility fractures 5= not indicated Diagnosis T-score based on WHO Osteoporosis Classification  2 years after initial diagnosis from the new patient cohort (+/-6 months).  Diagnosis date: -Diagnosed at the clinic: date of the multi-disciplinary meeting.
-Diagnosed somewhere else: date letter lung physician when the diagnosis is announced.  The retrospective patients which are still being treated will also be taken into account 5 years after initial diagnosis. Timing: 2 and/or 5 year after diagnosis. Reporting Source: clinical Response options: 1: resolved never treated 2: resolved, no therapy >1 year 3: minimal disease never treated 4: minimal disease no therapy > 1 year 5: persistent-no current therapy, never treated 6: persistent-no current therapy, no therapy > 1 year 7: persistent-current therapy, asymptomatic 8: persistent-current therapy, symptomatic 9: persistent-current therapy, worsening prior year 999 = unknown Baughman, R. P., Nagai, S., & Balter, M. (2011 comorbidity 2 = myocardial infarction 3 = congestive heart failure 4 = coronary artery disease 5 = cerebrovascular disease 6 = dementia 7 = COPD 8 = connective tissue disease 9 = peptic ulcer disease 10 = diabetes mellitus 11 = chronic kidney disease 12 = hemiplegia 13 = systemic hypertension 14 = liver disease mild 15 = liver disease moderate to severe 16 = other cancer (within last 5 years) 17 = peripheral vascular disease 18 = sleep apnoea 999 = unknown *The assumption here is that most important comorbidities are registered in the electronic patient record.
 Multi organ involvement Variable: mulita-organ involvement Definition: mulita-organ involvement regarding sarcoidosis, based on the WASOG multi-organ involvement in patients with confirmed sarcoidosis (Table 1) 
SARCOIDOSIS -Outcome Indicators prioritized

